Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.
A more in-depth interpretation of MMPI-2 in MS patients by using Harris and Lingoes subscales.
Azo polymeric micelles designed for colon-targeted dimethyl fumarate delivery for colon cancer therapy.
"Venous congestion" as a cause of subcortical white matter T2 hypointensity on magnetic resonance images.
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
Measurement properties of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ): a study based on Classical Test Theory.
Sensory information treatment during disturbed standing posture in chronic acquired demyelinating polyneuropathies (CADP).
In Vivo Gene Transfer to Schwann Cells in the Rodent Sciatic Nerve by Electroporation.
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.
Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful?
Conditional Deletion of the L-Type Calcium Channel Cav1.2 in Oligodendrocyte Progenitor Cells Affects Postnatal Myelination in Mice.
Neonatal Dexamethasone Treatment Exacerbates Hypoxia/Ischemia-Induced White Matter Injury.
Back Cover: Eur. J. Immunol. 7'16.
Safety of secukinumab in the treatment of psoriasis.
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis.
Multiple sclerosis activated by anti-tumor necrosis factor α (Etanercept) and the genetic risk.
Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice.
Placental Stromal Cell Therapy for Experimental Autoimmune Encephalomyelitis: The Role of Route of Cell Delivery.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms.
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.
Construct validity of the walk ratio as a measure of gait control in people with multiple sclerosis without mobility aids.
Vascularized nerve grafts: an experimental study.
Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone.
MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro.
Pages
« first
‹ previous
…
782
783
784
785
786
787
788
789
790
…
next ›
last »